BRANDIE CRAWFORD: Open Payments
NPI 1194244558 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 14 payments from 6 companies in 2025. Trend: 2023 $262 · 2024 $197 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $108 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| ABBVIE INC. | 2 | $34 |
| Novo Nordisk Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, Ozempic, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
